Quest Diagnostics (DGX) Receivables - Other (2009 - 2021)

Quest Diagnostics has disclosed Receivables - Other across 9 years of filings, most recently posting $5.0 million for Q1 2021.

• Receivables - Other for Q1 2021 came in at $5.0 million, changed 0.0% year-over-year; the trailing twelve-month figure through Mar 2021 was $5.0 million (changed 0.0% YoY), and the FY2020 annual result was $3.0 million, down 25.0% from the prior year.
• Receivables - Other came in at $5.0 million for Q1 2021 at Quest Diagnostics, up from $3.0 million in the prior quarter.
• In the past five years, Receivables - Other ranged from a high of $13.0 million in Q2 2017 to a low of $2.0 million in Q1 2019.
• The 5-year median for Receivables - Other is $4.0 million (2018), against an average of $4.6 million.
• Across the five-year window, Receivables - Other sank 76.92% in 2018 and soared 150.0% in 2020, its largest moves.
• Quest Diagnostics' Receivables - Other stood at $3.0 million in 2017, then changed by 0.0% to $3.0 million in 2018, then surged by 33.33% to $4.0 million in 2019, then declined by 25.0% to $3.0 million in 2020, then jumped by 66.67% to $5.0 million in 2021.
• The last three Receivables - Other figures came in at $5.0 million (Q1 2021), $3.0 million (Q4 2020), and $4.0 million (Q3 2020), per Business Quant data.